Development of mRNA vaccines against herpes zoster. [PDF]
Li D +9 more
europepmc +1 more source
Precision Adjuvant Strategies in Vaccine Development for Substance Use Disorders: Variability and Mechanistic Insights. [PDF]
Bian Y, Ci Q, Luo XM, Zhang C.
europepmc +1 more source
Effects of MF59 Adjuvant on Induction of Isotype-Switched IgG Antibodies and Protection after Immunization with T-Dependent Influenza Virus Vaccine in the Absence of CD4+ T Cells. [PDF]
Ko EJ +6 more
europepmc +1 more source
Development and Characterization of a Stable Oil-in-Water Nanoemulsion Using Impingement Jet Mixing and Lyophilization Techniques. [PDF]
Shao A +7 more
europepmc +1 more source
Design and mechanistic insights into ZMF59/CpG: a complementary adjuvant system boosting immunity and safety in herpes zoster vaccines. [PDF]
Bian L +13 more
europepmc +1 more source
Comparing HIV Vaccine Immunogenicity Across Trials With Different Populations and Study Designs. [PDF]
Jin Y +4 more
europepmc +1 more source
Next-generation Candida albicans vaccine VXV-01 containing recombinant Als3p and Hyr1p antigens for invasive Candida infections. [PDF]
Singh S +10 more
europepmc +1 more source
Vaccine Responses in Early Age. [PDF]
Parvathaneni S +3 more
europepmc +1 more source
Effect of Different Adjuvants on the Immunogenicity of a Recombinant Herpes Zoster Vaccine in Mice, Rats and Non-Human Primates. [PDF]
Liu X +9 more
europepmc +1 more source

